-
1
-
-
0033517302
-
The effect of spironolactone on morbidity and mortality in patients with severe heart failure
-
DOI 10.1056/NEJM199909023411001
-
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomised Aldactone Evaluation Study Investigators. N Eng J Med 1999;341:709-717. (Pubitemid 29407370)
-
(1999)
New England Journal of Medicine
, vol.341
, Issue.10
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
Cody, R.4
Castaigne, A.5
Perez, A.6
Palensky, J.7
Wittes, J.8
-
2
-
-
0037417252
-
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
-
DOI 10.1056/NEJMoa030207
-
Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, for the Eplerenone post-acute myocardial infarction heart failure efficacy and survival study investigators. Eplerenone, a selective aldoster-one blocker in patients with left ventricular dysfunction after myocardial infarction. N Eng J Med 2003;348:1309-21. (Pubitemid 36384098)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.14
, pp. 1309-1321
-
-
Pitt, B.1
Remme, W.2
Zannad, F.3
Neaton, J.4
Martinez, F.5
Roniker, B.6
Bittman, R.7
Hurley, S.8
Kleiman, J.9
Gatlin, M.10
-
3
-
-
53549085406
-
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008
-
The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
-
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 933-989
-
-
Dickstein, K.1
Cohen-Solal, A.2
Filippatos, G.3
McMurray, J.J.4
Ponikowski, P.5
Poole-Wilson, P.A.6
Stromberg, A.7
Van Veldhuisen, D.J.8
Atar, D.9
Hoes, A.W.10
Keren, A.11
Mebazaa, A.12
Nieminen, M.13
Priori, S.G.14
Swedberg, K.15
-
4
-
-
62449296975
-
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): Final results
-
on behalf of the AREA IN-CHF Investigators
-
Boccanelli A, Mureddu GF, Ciacciatore G, Clemenza F, Di Lenarda A, Gavazzi A, Porcu M, Latini R, Lucci D, Maggioni AP, Masson S, Vanasia M, de Simone G, on behalf of the AREA IN-CHF Investigators. Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results. Eur J Heart Fail 2009;11:68-76.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 68-76
-
-
Boccanelli, A.1
Mureddu, G.F.2
Ciacciatore, G.3
Clemenza, F.4
Di Lenarda, A.5
Gavazzi, A.6
Porcu, M.7
Latini, R.8
Lucci, D.9
Maggioni, A.P.10
Masson, S.11
Vanasia, M.12
De Simone, G.13
-
5
-
-
77954739690
-
Randomized double-blind multicentre placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodelling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction
-
Udelson JE, Feldman AM, Greenberg B, Pitt B, Mukherjee R, Solomon HA, Konstam MA. Randomized double-blind multicentre placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodelling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction. Circ Heart Fail 2010;3:347-353.
-
(2010)
Circ Heart Fail
, vol.3
, pp. 347-353
-
-
Udelson, J.E.1
Feldman, A.M.2
Greenberg, B.3
Pitt, B.4
Mukherjee, R.5
Solomon, H.A.6
Konstam, M.A.7
-
6
-
-
77952962152
-
Rationale and design of the eplerenone in mild patients hospitalization and survival study in heart failure (EMPHASIS-HF)
-
Zannad F, McMurray JJV, Drexler H, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B. Rationale and design of the eplerenone in mild patients hospitalization and survival study in heart failure (EMPHASIS-HF). Eur J Heart Fail 2010;12:617-622.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 617-622
-
-
Zannad, F.1
Jjv, M.2
Drexler, H.3
Krum, H.4
Van Veldhuisen, D.J.5
Swedberg, K.6
Shi, H.7
Vincent, J.8
Pitt, B.9
-
7
-
-
78650399880
-
Eplerenone in patients with systolic heart failure and mild symptoms
-
Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pocock SJ, Pitt B. Eplerenone in patients with systolic heart failure and mild symptoms. N Eng J Med 2011;364:11-21.
-
(2011)
N Eng J Med
, vol.364
, pp. 11-21
-
-
Zannad, F.1
Jjv, M.2
Krum, H.3
Van Veldhuisen, D.J.4
Swedberg, K.5
Shi, H.6
Vincent, J.7
Pocock, S.J.8
Pitt, B.9
-
8
-
-
78649370678
-
Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1(c) levels in patients with chronic heart failure
-
Yamaji M, Tsutamoto T, Kawahara C, Nishiyama K, Yamamoto T, Fuji M, Horie M. Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1(c) levels in patients with chronic heart failure. Am Heart J 2010;160:915-921.
-
(2010)
Am Heart J
, vol.160
, pp. 915-921
-
-
Yamaji, M.1
Tsutamoto, T.2
Kawahara, C.3
Nishiyama, K.4
Yamamoto, T.5
Fuji, M.6
Horie, M.7
-
9
-
-
72949104923
-
Implementation of device therapy (cardiac resynchronisation therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: Changes from 2004 to 2008
-
van Veldhuisen DJ, Maas AH, Priori SG, Stolt P, van Gelder IC, Dickstein K, Swedberg K. Implementation of device therapy (cardiac resynchronisation therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008. Eur J Heart Fail 2009;11: 1143-1151.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 1143-1151
-
-
Van Veldhuisen, D.J.1
Maas, A.H.2
Priori, S.G.3
Stolt, P.4
Van Gelder, I.C.5
Dickstein, K.6
Swedberg, K.7
-
10
-
-
70349625757
-
Cardiac resynchronisation therapy for the prevention of heart failure events
-
the MADIT-CRT trial investigators
-
Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, the MADIT-CRT trial investigators. Cardiac resynchronisation therapy for the prevention of heart failure events. N Eng J Med 2009;361: 1329-1338.
-
(2009)
N Eng J Med
, vol.361
, pp. 1329-1338
-
-
Moss, A.J.1
Hall, W.J.2
Cannom, D.S.3
Klein, H.4
Brown, M.W.5
Daubert, J.P.6
Estes, N.A.7
Foster, E.8
Greenberg, H.9
Higgins, S.L.10
Pfeffer, M.A.11
Solomon, S.D.12
Wilber, D.13
Zareba, W.14
-
11
-
-
78650215892
-
Cardiac resynchronization therapy for mild to moderate heart failure
-
for the RAFT Investigators
-
Tang ASL, Wells GA, Talajic M, Arnold MO, Sheldon R, Connelly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL, for the RAFT Investigators. Cardiac resynchronization therapy for mild to moderate heart failure. N Eng J Med 2010;363:2385-2395.
-
(2010)
N Eng J Med
, vol.363
, pp. 2385-2395
-
-
Asl, T.1
Wells, G.A.2
Talajic, M.3
Arnold, M.O.4
Sheldon, R.5
Connelly, S.6
Hohnloser, S.H.7
Nichol, G.8
Birnie, D.H.9
Sapp, J.L.10
Yee, R.11
Healey, J.S.12
Rouleau, J.L.13
-
12
-
-
30744464127
-
Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction - a systematic review and meta-analysis
-
DOI 10.1016/j.ejheart.2005.11.014, PII S1388984205003399
-
Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JGF. Cardiac resynchronisation for patients with heart failure due to left ventricular systolic dysfunction-a systematic review and meta-analysis. Eur J Heart Fail 2006;8:433-440. (Pubitemid 43832169)
-
(2006)
European Journal of Heart Failure
, vol.8
, Issue.4
, pp. 433-440
-
-
Freemantle, N.1
Tharmanathan, P.2
Calvert, M.J.3
Abraham, W.T.4
Ghosh, J.5
Cleland, J.G.F.6
-
13
-
-
56349114416
-
Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms
-
REVERSE Study Group
-
Linde C, Abraham WT, Gold MR, St John Sutton M, Ghio S, Daubert C, REVERSE Study Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52: 1834-1843.
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 1834-1843
-
-
Linde, C.1
Abraham, W.T.2
Gold, M.R.3
St John Sutton, M.4
Ghio, S.5
Daubert, C.6
-
14
-
-
33748058451
-
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]
-
DOI 10.1093/eurheartj/ehl099
-
Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. Longer term effects of cardiac resynchronization therapy on mortality in heart failure [the cardiac resynchronization-heart failure (CARE-HF) trial extension phase]. Eur Heart J 2006;16:1928-1932. (Pubitemid 44297365)
-
(2006)
European Heart Journal
, vol.27
, Issue.16
, pp. 1928-1932
-
-
Cleland, J.G.F.1
Daubert, J.-C.2
Erdmann, E.3
Freemantle, N.4
Gras, D.5
Kappenberger, L.6
Tavazzi, L.7
-
15
-
-
39749194940
-
Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: A report from the CARE-HF study
-
DOI 10.1136/hrt.2007.128991
-
Cleland JGF, Freemantle N, Daubert JC, Toff WD, Leisch F, Tavazzi L. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study. Heart 2008;94:278-283. (Pubitemid 351303415)
-
(2008)
Heart
, vol.94
, Issue.3
, pp. 278-283
-
-
Cleland, J.G.F.1
Freemantle, N.2
Daubert, J.-C.3
Toff, W.D.4
Leisch, F.5
Tavazzi, L.6
-
16
-
-
77958545980
-
2010 Focused update of ESC guidelines on device therapy in heart failure
-
Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J, Ponikowski P, Priori SG, Sutton R, van Veldhuisen DJ. 2010 Focused update of ESC guidelines on device therapy in heart failure. Eur J Heart Fail 2010;12: 1143-1153.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 1143-1153
-
-
Dickstein, K.1
Vardas, P.E.2
Auricchio, A.3
Daubert, J.C.4
Linde, C.5
McMurray, J.6
Ponikowski, P.7
Priori, S.G.8
Sutton, R.9
Van Veldhuisen, D.J.10
-
17
-
-
79953156220
-
Which components of heart failure programmes are effective? A meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 9,560 patients (Abridged Cochrane Review)
-
in press doi:10.1093/eurjhf/hfr039
-
Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JGF. Which components of heart failure programmes are effective? A meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 9,560 patients (Abridged Cochrane Review). Eur J Heart Fail 2011 (in press); doi:10.1093/eurjhf/hfr039.
-
(2011)
Eur J Heart Fail
-
-
Inglis, S.C.1
Clark, R.A.2
McAlister, F.A.3
Stewart, S.4
Jgf, C.5
-
18
-
-
78649660294
-
Telemedical interventional monitoring in heart failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: Study design
-
Koehler F, Winkler S, Scheiber M, Sechtem U, Stangl K, Bohm M, Boll H, Kim SS, Koeler K, Lucke S, Honold M, Heinz P, Schweizer T, Braecklein M, Kirwan BA, Gelbrich G, Anker SA. Telemedical interventional monitoring in heart failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. Eur J Heart Fail 2010;12:1354-1362.
-
(2010)
Eur J Heart Fail
, vol.12
, pp. 1354-1362
-
-
Koehler, F.1
Winkler, S.2
Scheiber, M.3
Sechtem, U.4
Stangl, K.5
Bohm, M.6
Boll, H.7
Kim, S.S.8
Koeler, K.9
Lucke, S.10
Honold, M.11
Heinz, P.12
Schweizer, T.13
Braecklein, M.14
Kirwan, B.A.15
Gelbrich, G.16
Anker, S.A.17
-
19
-
-
78649835638
-
Telemonitoring in patients with heart failure
-
Chaudry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM. Telemonitoring in patients with heart failure. N Eng J Med 2010;363:2301-2309.
-
(2010)
N Eng J Med
, vol.363
, pp. 2301-2309
-
-
Chaudry, S.I.1
Mattera, J.A.2
Curtis, J.P.3
Spertus, J.A.4
Herrin, J.5
Lin, Z.6
Phillips, C.O.7
Hodshon, B.V.8
Cooper, L.S.9
Krumholz, H.M.10
-
20
-
-
0037142946
-
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial
-
DOI 10.1016/S0140-6736(02)09455-2
-
Follath F, Cleland JGF, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002;360:196-202. (Pubitemid 34804646)
-
(2002)
Lancet
, vol.360
, Issue.9328
, pp. 196-202
-
-
Follath, F.1
Cleland, J.G.F.2
Just, H.3
Papp, J.G.Y.4
Scholz, H.5
Peuhkurinen, K.6
Harjola, V.P.7
Mitrovic, V.8
Abdalla, M.9
Sandell, E.-P.10
Lehtonen, L.11
-
21
-
-
34247857479
-
Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE randomized trial
-
DOI 10.1001/jama.297.17.1883
-
Mebazza A, Nieminen M, Packer M, Cohen-Solal A, Kleber FX, Pocock S, Thakkar R, Padley RJ, Poder P, Kivikko M, SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute decompensated heart failure the SURVIVE randomized trial. JAMA 2007;297:1883-1891. (Pubitemid 46707842)
-
(2007)
Journal of the American Medical Association
, vol.297
, Issue.17
, pp. 1883-1891
-
-
Mebazaa, A.1
Nieminen, M.S.2
Packer, M.3
Cohen-Solal, A.4
Kleber, F.X.5
Pocock, S.J.6
Thakkar, R.7
Padley, R.J.8
Poder, P.9
Kivikko, M.10
-
22
-
-
35848944656
-
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: The VERITAS randomized controlled trials
-
DOI 10.1001/jama.298.17.2009
-
McMurray JJ, Teerlink JR, Cotter G, Bourge RC, Cleland JG, Jondeau G, Krum H, Metra M, O'Connor CM, Parker JD, Torre-Amione G, van Veldhuisen DJ, Lewsley J, Frey A, Rainisio M, Kobrin I, VERITAS Investigators. Effects of tezosen-tan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 2007;298:2009-2019. (Pubitemid 350074798)
-
(2007)
Journal of the American Medical Association
, vol.298
, Issue.17
, pp. 2009-2019
-
-
McMurray, J.J.V.1
Teerlink, J.R.2
Cotter, G.3
Bourge, R.C.4
Cleland, J.G.F.5
Jondeau, G.6
Krum, H.7
Metra, M.8
O'Connor, C.M.9
Parker, J.D.10
Torre-Amione, G.11
Van Veldhuisen, D.J.12
Lewsey, J.13
Frey, A.14
Rainisio, M.15
Kobrin, I.16
-
23
-
-
72949111668
-
-
Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT
-
Cleland JGF, Coletta AP, Yassin A, Buga L, Torabi A, Clark AL. Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT. Eur J Heart Fail 2009;11:1214-1219.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 1214-1219
-
-
Jgf, C.1
Coletta, A.P.2
Yassin, A.3
Buga, L.4
Torabi, A.5
Clark, A.L.6
-
24
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
and the RELY Steering Committee and Investigators
-
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis B, Darius H, Diener H, Joyner CD, Wallentin L and the RELY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Eng J Med 2009;361:1139-1151.
-
(2009)
N Eng J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
Eikelboom, J.4
Oldgren, J.5
Parekh, A.6
Pogue, J.7
Reilly, P.A.8
Themeles, E.9
Varrone, J.10
Wang, S.11
Alings, M.12
Xavier, D.13
Zhu, J.14
Diaz, R.15
Lewis, B.16
Darius, H.17
Diener, H.18
Joyner, C.D.19
Wallentin, L.20
more..
-
25
-
-
67749098636
-
-
Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA and OMEGA
-
Cleland JGF, Coletta AP, Clark AL, Cullington D. Clinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF-5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA and OMEGA. Eur J Heart Fail 2009;11:622-630.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 622-630
-
-
Jgf, C.1
Coletta, A.P.2
Clark, A.L.3
Cullington, D.4
-
26
-
-
51549120537
-
State of the art: Using natriuretic peptide levels in clinical practice
-
Maisel A, Muller C, Adams K, Anker S, Aspromonte N, Cleland JG, Cohen-Solal A, Dahlstrom U, DeMaria A, Di Somma S, Fillipatos GS, Fonarow GC, Jourdain P, Komajda M, Liu PP, McDonagh T, McDonald K, Mebazza A, Nieminen M, Peacock WF, Tubaro M, Valle R, Vanderheyden M, Yancy C, Zannad F, Braunwald E. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008;10:824-839.
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 824-839
-
-
Maisel, A.1
Muller, C.2
Adams, K.3
Anker, S.4
Aspromonte, N.5
Cleland, J.G.6
Cohen-Solal, A.7
Dahlstrom, U.8
Demaria, A.9
Di Somma, S.10
Fillipatos, G.S.11
Fonarow, G.C.12
Jourdain, P.13
Komajda, M.14
Liu, P.P.15
McDonagh, T.16
McDonald, K.17
Mebazza, A.18
Nieminen, M.19
Peacock, W.F.20
Tubaro, M.21
Valle, R.22
Vanderheyden, M.23
Yancy, C.24
Zannad, F.25
Braunwald, E.26
more..
-
27
-
-
68849114272
-
Biomarker guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
-
Felker GM, Hasselblad V, Hernandez AF, O'Connor CM. Biomarker guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials. Am Heart J 2009;158:422-430.
-
(2009)
Am Heart J
, vol.158
, pp. 422-430
-
-
Felker, G.M.1
Hasselblad, V.2
Hernandez, A.F.3
O'Connor, C.M.4
|